Interacción entre la petidina y la selegilina.

Same author

Shifting boundaries: gender in "Pinhua Baojian".

Nan nu : men, women, and gender in early and Imperial China·2011

Same author

Hypothetical fears and quantitative risk analysis.

Risk analysis : an official publication of the Society for Risk Analysis·2002

Same author

The ultimate uncertainty--intergenerational planning.

Risk analysis : an official publication of the Society for Risk Analysis·2001

Same author

Moving on, moving up. Your career guide. Some are meant to lead. Maybe you.

Medical economics·2001

Same author

A lifelong ally for cystic fibrosis patients.

Medical economics·2000

Same author

Exploring complementary therapies in conventional practice.

JAAPA : official journal of the American Academy of Physician Assistants·2000

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Interacción entre la petidina y la selegilina.

Videos de Conceptos Relacionados

Shifting boundaries: gender in "Pinhua Baojian".

Hypothetical fears and quantitative risk analysis.

The ultimate uncertainty--intergenerational planning.

Moving on, moving up. Your career guide. Some are meant to lead. Maybe you.

A lifelong ally for cystic fibrosis patients.

Exploring complementary therapies in conventional practice.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Videos de Experimentos Relacionados

Interacción entre la petidina y la selegilina.

Videos de Conceptos Relacionados

Artículos Relacionados

Shifting boundaries: gender in "Pinhua Baojian".

Hypothetical fears and quantitative risk analysis.

The ultimate uncertainty--intergenerational planning.

Moving on, moving up. Your career guide. Some are meant to lead. Maybe you.

A lifelong ally for cystic fibrosis patients.

Exploring complementary therapies in conventional practice.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.